Roth JA - Search Results

1

TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.

Meraz IM, Majidi M, Cao X, Lin H, Li L, Wang J, Baladandayuthapani V, Rice D, Sepesi B, Ji L, Roth JA. Meraz IM, et al. Among authors: roth ja. Cancer Immunol Res. 2018 Feb;6(2):163-177. doi: 10.1158/2326-6066.CIR-17-0273. Epub 2018 Jan 16. Cancer Immunol Res. 2018. PMID: 29339375 Free PMC article.

2

New approaches to treating early lung cancer.

Roth JA. Roth JA. Cancer Res. 1992 May 1;52(9 Suppl):2652s-2657s. Cancer Res. 1992. PMID: 1562995 Review.

3

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

Yang SC, Grimm EA, Parkinson DR, Carinhas J, Fry KD, Mendiguren-Rodriguez A, Licciardello J, Owen-Schaub LB, Hong WK, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1991 Jul 15;51(14):3669-76. Cancer Res. 1991. PMID: 1648441 Clinical Trial.

4

p53 gene mutations in Barrett's epithelium and esophageal cancer.

Casson AG, Mukhopadhyay T, Cleary KR, Ro JY, Levin B, Roth JA. Casson AG, et al. Among authors: roth ja. Cancer Res. 1991 Aug 15;51(16):4495-9. Cancer Res. 1991. PMID: 1868473

5

Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.

Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. Mukhopadhyay T, et al. Among authors: roth ja. Cancer Res. 1991 Mar 15;51(6):1744-8. Cancer Res. 1991. PMID: 1998965

6

Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.

Yang SC, Owen-Schaub LB, Roth JA, Grimm EA. Yang SC, et al. Among authors: roth ja. Cancer Res. 1990 Jun 15;50(12):3526-32. Cancer Res. 1990. PMID: 2160321

7

Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-alpha against primary lung cancer targets.

Yang SC, Owen-Schaub L, Grimm EA, Roth JA. Yang SC, et al. Among authors: roth ja. Cancer Immunol Immunother. 1989;29(3):193-8. doi: 10.1007/BF00199995. Cancer Immunol Immunother. 1989. PMID: 2543502 Free PMC article.

8

Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer.

Schneider PM, Hung MC, Chiocca SM, Manning J, Zhao XY, Fang K, Roth JA. Schneider PM, et al. Among authors: roth ja. Cancer Res. 1989 Sep 15;49(18):4968-71. Cancer Res. 1989. PMID: 2569928

9

Analysis of gp74 expression by transformed rat fibroblasts from experimental pulmonary metastases following specific ricin A-chain immunotoxin therapy.

Roth JA, Thomsen S, Fry KD, Scannon P, Chang C. Roth JA, et al. Cancer Res. 1989 Oct 15;49(20):5708-12. Cancer Res. 1989. PMID: 2676148

10

Molecular events in lung cancer.

Roth JA. Roth JA. Lung Cancer. 1995 Jun;12 Suppl 2:S3-15. doi: 10.1016/s0169-5002(10)80002-9. Lung Cancer. 1995. PMID: 7551947 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,251 results

Search Page

Filters